ChromaDex Corporation (CDXC)

Develops and commercializes evidence-based dietary supplements, focusing on healthy aging and wellness.

CDXC Stock Quote

Company Report

ChromaDex Corporation, based in Los Angeles, California, operates as a bioscience company with a primary focus on promoting healthy aging. The company is structured into three key segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services.

In the realm of consumer products, ChromaDex specializes in developing and distributing finished dietary supplements containing proprietary ingredients directly to consumers and distributors. It is particularly renowned for its research and development in nicotinamide adenine dinucleotide (NAD+), leveraging this vital coenzyme's potential benefits in health and aging. The flagship ingredient NIAGEN, a form of NAD+ precursor nicotinamide riboside, is prominently featured in their consumer products under the brand name TRU NIAGEN.

ChromaDex also plays a pivotal role in the ingredients sector, where it commercializes and supplies proprietary-based ingredient technologies to manufacturers in the consumer products industry. Additionally, the company provides analytical reference standards and services crucial for quality control in raw materials and consumer products across dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical sectors. ChromaDex distributes its TRU NIAGEN products directly to consumers through its proprietary e-commerce platform TRUNIAGEN.com, as well as through Amazon, specialty retailers, and direct healthcare practitioners in the United States.

CDXC EPS Chart

CDXC Revenue Chart

Stock Research

SYT EHGO LCUT ALCC WEAV NKTR SCVL

CDXC Chart

View interactive chart for CDXC

CDXC Profile

CDXC News

Analyst Ratings